Several works have pointed out its capacity to promote cell cycle arrest, together with the downregulation of MYC, BRD2, and BRD4 protein levels and upregulation of the PolII negative transcription regulator, HEXIM1, in human AML and ALL cell lines and primary samples [75]. The gene discussed is BRD2; the disease is acute lymphoblastic leukemia.